The DOI matches its Crossref record; 167 of the 167 references it cites were found in a registry or an index.
The 2012 Hormone Therapy Position Statement of The North American Menopause Society
Open accessAbstract
In Brief Objective This position statement aimed to update the evidence-based position statement published by The North American Menopause Society (NAMS) in 2010 regarding recommendations for hormone therapy (HT) for postmenopausal women. This updated position statement further distinguishes the emerging differences in the therapeutic benefit-risk ratio between estrogen therapy (ET) and combined estrogen-progestogen therapy (EPT) at various ages and time intervals since menopause onset. Methods An Advisory Panel of expert clinicians and researchers in the field of women’s health was enlisted to review the 2010 NAMS position statement, evaluate new evidence, and reach consensus on recommendations. The Panel’s recommendations were reviewed and approved by the NAMS Board of Trustees as an official NAMS position statement. Results Current evidence supports the use of HT for perimenopausal and postmenopausal women when the balance of potential benefits and risks is favorable for the individual woman. This position statement reviews the effects of ET and EPT on many aspects of women’s health and recognizes the greater safety profile associated with ET. Conclusions Recent data support the initiation of HT around the time of menopause to treat menopause-related symptoms and to prevent osteoporosis in women at high risk of fracture. The more favorable benefit-risk ratio for ET allows more flexibility in extending the duration of use compared with EPT, where the earlier appearance of increased breast cancer risk precludes a recommendation for use beyond 3 to 5 years. The updated, evidence-based hormone therapy position statement of The North American Menopause Society further distinguishes the emerging differences in the therapeutic benefit-risk ratio between estrogen therapy and combined estrogen-progestogen therapy at various ages and time intervals since menopause onset.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Writing Group for the Women's Health Initiative Investigators (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.3.321 · Cited by 15,889
Hulley, S. (1998) · JAMA · doi:10.1001/jama.280.7.605 · Cited by 6,216
Hormone Therapy To Prevent Disease and Prolong Life in Postmenopausal Women
Grady, D., Rubin, S. M., Petitti, D. B., Fox, C. S., Black, D., Ettinger, B., Ernster, V. L., & Cummings, S. R. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-12-1016 · Cited by 2,336
Shumaker, S. A., Legault, C., Rapp, S. R., Thal, L., Wallace, R. B., Ockene, J. K., Hendrix, S. L., Jones III, B. N., Assaf, A. R., Jackson, R. D., et al. (2003) · JAMA · doi:10.1001/jama.289.20.2651 · Cited by 2,178
Estrogen plus Progestin and the Risk of Coronary Heart Disease
Manson, J. E., Hsia, J., Johnson, K. C., Rossouw, J. E., Assaf, A. R., Lasser, N. L., Trevisan, M., Black, H. R., Heckbert, S. R., Detrano, R., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030808 · Cited by 2,065
Giudice, L. C. (2010) · New England Journal of Medicine · doi:10.1056/nejmcp1000274 · Cited by 1,924
Calcium plus Vitamin D Supplementation and the Risk of Fractures
Jackson, R. D., LaCroix, A. Z., Gass, M., Wallace, R. B., Robbins, J., Lewis, C. E., Bassford, T., Beresford, S. A. A., Black, H. R., Blanchette, P., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055218 · Cited by 1,883
Chlebowski, R. T., Hendrix, S. L., Langer, R. D., Stefanick, M. L., Gass, M., Lane, D., Rodabough, R. J., Gilligan, M. A., Cyr, M. G., Thomson, C. A., et al. (2003) · JAMA · doi:10.1001/jama.289.24.3243 · Cited by 1,872
Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause
Rossouw, J. E., Prentice, R. L., Manson, J. E., Wu, L., Barad, D., Barnabei, V. M., Ko, M., LaCroix, A. Z., Margolis, K. L., & Stefanick, M. L. (2007) · JAMA · doi:10.1001/jama.297.13.1465 · Cited by 1,741
The use of estrogens and progestins and the risk of breast cancer in postmenopausal women.
Colditz, G. A., Hankinson, S. E., Hunter, D. J., Willett, W. C., Manson, J. E., Stampfer, M. J., Hennekens, C., Rosner, B., & Speizer, F. E. (1995) · New England Journal of Medicine · doi:10.1056/nejm199506153322401 · Cited by 1,487
Estrogen and coronary heart disease in women
Barrett-Connor, E. (1991) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1991.03460140089033 · Cited by 1,241
Cauley, J. A. (2003) · JAMA · doi:10.1001/jama.290.13.1729 · Cited by 1,221
Wassertheil-Smoller, S., Hendrix, S., Limacher, M., Heiss, G., Kooperberg, C., Baird, A., Kotchen, T., Curb, J. D., Black, H., Rossouw, J. E., et al. (2003) · JAMA · doi:10.1001/jama.289.20.2673 · Cited by 1,159
Grodstein, F., Manson, J. E., Colditz, G. A., Willett, W. C., Speizer, F. E., & Stampfer, M. J. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-12-200012190-00008 · Cited by 1,063 · cited 1×
“duration of HT use is associated with a reduced risk of CHD and related mortality.(166) The WHI RCTs and observational study suggest a pattern of lower risk of CHD among women who used HT for 5 or more years,(40) but this is not conclusive and should be considered in light of other factors altered by duration of thera…”
Hormone replacement therapy and endometrial cancer risk: A meta-analysis
GRADY, D., GEBRETSADIK, T., KERLIKOWSKE, K., ERNSTER, V, & PETITTI, D. (1995) · Obstetrics & Gynecology · doi:10.1016/0029-7844(94)00383-o · Cited by 962
Estrogen Therapy in Postmenopausal Women: Effects on Cognitive Function and Dementia
Yaffe, K., Sawaya, G., Lieberburg, I., & Grady, D. (1998) · JAMA · doi:10.1001/jama.279.9.688 · Cited by 941
Raz, R., & Stamm, W. E. (1993) · New England Journal of Medicine · doi:10.1056/nejm199309093291102 · Cited by 928
A Clinical Trial of Estrogen-Replacement Therapy after Ischemic Stroke
Viscoli, C. M., Brass, L. M., Kernan, W. N., Sarrel, P. M., Suissa, S., & Horwitz, R. I. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010534 · Cited by 921
Canonico, M., Oger, E., Plu-Bureau, G., Conard, J., Meyer, G., Lévesque, H., Trillot, N., Barrellier, M.-T., Wahl, D., Emmerich, J., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.642280 · Cited by 864
Factors Associated with Age at Natural Menopause in a Multiethnic Sample of Midlife Women
Gold, E. B. (2001) · American Journal of Epidemiology · doi:10.1093/aje/153.9.865 · Cited by 863
Cohen, L. S., Soares, C. N., Vitonis, A. F., Otto, M. W., & Harlow, B. L. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.4.385 · Cited by 831
Rocca, W. A., Bower, J. H., Maraganore, D. M., Ahlskog, J. E., Grossardt, B. R., de Andrade, M., & Melton, L. J. (2007) · Neurology · doi:10.1212/01.wnl.0000276984.19542.e6 · Cited by 827
Effects of estrogen on memory function in surgically menopausal women
Phillips, S. (1992) · Psychoneuroendocrinology · doi:10.1016/0306-4530(92)90007-t · Cited by 741
Scarabin, P.-Y., Oger, E., & Plu-Bureau, G. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14066-4 · Cited by 714
Estrogen Therapy and Coronary-Artery Calcification
Manson, J. E., Allison, M. A., Rossouw, J. E., Carr, J. J., Langer, R. D., Hsia, J., Kuller, L. H., Cochrane, B. B., Hunt, J. R., Ludlam, S. E., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa071513 · Cited by 711
Sherwin, B. B. (1988) · Psychoneuroendocrinology · doi:10.1016/0306-4530(88)90060-1 · Cited by 703
de Novaes Soares, C., Almeida, O. P., Joffe, H., & Cohen, L. S. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.6.529 · Cited by 691
Estrogen in the Prevention of Atherosclerosis: A Randomized, Double-Blind, Placebo-Controlled Trial
Hodis, H. N., Mack, W. J., Lobo, R. A., Shoupe, D., Sevanian, A., Mahrer, P. R., Selzer, R. H., Liu, C.-R., Liu, C.-H., Azen, S. P., et al. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-11-200112040-00005 · Cited by 687
Effects of estrogen plus progestin on health-related quality of life
Hays, J., Ockene, J. K., Brunner, R. L., Kotchen, J. M., Manson, J. E., Patterson, R. E., Aragaki, A. K., Shumaker, S. A., Brzyski, R. G., LaCroix, A. Z., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030311 · Cited by 686
Parker, W. H., Broder, M. S., Chang, E., Feskanich, D., Farquhar, C., Liu, Z., Shoupe, D., Berek, J. S., Hankinson, S., & Manson, J. E. (2009) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e3181a11c64 · Cited by 640
Kanaya, A. M., Herrington, D., Vittinghoff, E., Lin, F., Grady, D., Bittner, V., Cauley, J. A., & Barrett-Connor, E. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-1-200301070-00005 · Cited by 633
Estrogen plus progestin and risk of venous thrombosis
Cushman, M. (2004) · JAMA · doi:10.1001/jama.292.13.1573 · Cited by 632
Conjugated Equine Estrogens and Coronary Heart Disease: The Women's Health Initiative
Hsia, J. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.3.357 · Cited by 610
Menopausal Hormone Replacement Therapy and Risk of Ovarian Cancer
Lacey, Jr. (2002) · JAMA · doi:10.1001/jama.288.3.334 · Cited by 606
Local oestrogen for vaginal atrophy in postmenopausal women
Lethaby, A., Ayeleke, R. O., & Roberts, H. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001500.pub3 · Cited by 601
for the Women’s Health Initiative Investigators, Margolis, K. L., Bonds, D. E., Rodabough, R. J., Tinker, L., Phillips, L. S., Allen, C., Bassford, T., Burke, G., Torrens, J., et al. (2004) · Diabetologia · doi:10.1007/s00125-004-1448-x · Cited by 599
HORMONE REPLACEMENT THERAPY, HEART DISEASE, AND OTHER CONSIDERATIONS
Barrett-Connor, E., & Grady, D. (1998) · Annual Review of Public Health · doi:10.1146/annurev.publhealth.19.1.55 · Cited by 590
Estrogen replacement in perimenopause-related depression: A preliminary report
Schmidt, P. J., Nieman, L., Danaceau, M. A., Tobin, M. B., Roca, C. A., Murphy, J. H., & Rubinow, D. R. (2000) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2000.106004 · Cited by 578
Stefanick, M. L., Anderson, G. L., Margolis, K. L., Hendrix, S. L., Rodabough, R. J., Paskett, E. D., Lane, D. S., Hubbell, F. A., Assaf, A. R., Sarto, G. E., et al. (2006) · JAMA · doi:10.1001/jama.295.14.1647 · Cited by 571
Canonico, M., Plu-Bureau, G., Lowe, G. D. O., & Scarabin, P.-Y. (2008) · BMJ · doi:10.1136/bmj.39555.441944.be · Cited by 569 · cited 2×
“There is growing observational evidence that transdermal ET may be associated with a lower risk of deep vein thrombosis, stroke, and MI.(64,65,68,161) There are multiple progestogen dosing-regimen options for endometrial safety.”
Estrogen Plus Progestin and Breast Cancer Incidence and Mortality in Postmenopausal Women
Chlebowski, R. T., Anderson, G. L., Gass, M., Lane, D. S., Aragaki, A. K., Kuller, L. H., Manson, J. E., Stefanick, M. L., Ockene, J., Sarto, G. E., et al. (2010) · JAMA · doi:10.1001/jama.2010.1500 · Cited by 567
Luoma, P., Melberg, A., Rinne, J. O., Kaukonen, J. A., Nupponen, N. N., Chalmers, R. M., Oldfors, A., Rautakorpi, I., Peltonen, L., Majamaa, K., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16983-3 · Cited by 548
Oral oestrogen and combined oestrogen/progestogen therapy versus placebo for hot flushes
MacLennan, A. H., Broadbent, J. L., Lester, S., & Moore, V. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002978.pub2 · Cited by 543
LaCroix, A. Z. (2011) · JAMA · doi:10.1001/jama.2011.382 · Cited by 538
Recommendations for the management of postmenopausal vaginal atrophy
Sturdee, D. W., & Panay, N. (2010) · Climacteric · doi:10.3109/13697137.2010.522875 · Cited by 527
Prior to Use of Estrogen Replacement Therapy, Are Users Healthier than Nonusers?
Matthews, K. A., Kuller, L. H., Wing, R. R., Meilahn, E. N., & Plantinga, P. (1996) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a008678 · Cited by 517
Effects of Estrogen With and Without Progestin on Urinary Incontinence
Hendrix, S. L. (2005) · JAMA · doi:10.1001/jama.293.8.935 · Cited by 509
Colditz, G. A. (2000) · American Journal of Epidemiology · doi:10.1093/aje/152.10.950 · Cited by 487
Effects of the menopause transition and hormone use on cognitive performance in midlife women
Greendale, G. A., Huang, M.-H., Wight, R. G., Seeman, T., Luetters, C., Avis, N. E., Johnston, J., & Karlamangla, A. S. (2009) · Neurology · doi:10.1212/wnl.0b013e3181a71193 · Cited by 444
Estrogen Replacement Therapy and Ovarian Cancer Mortality in a Large Prospective Study of US Women
Rodriguez, C. (2001) · JAMA · doi:10.1001/jama.285.11.1460 · Cited by 424
Simon, J. A., Hsia, J., Cauley, J. A., Richards, C., Harris, F., Fong, J., Barrett-Connor, E., & Hulley, S. B. (2001) · Circulation · doi:10.1161/01.cir.103.5.638 · Cited by 403
Health Risks and Benefits 3 Years After Stopping Randomized Treatment With Estrogen and Progestin
Heiss, G. (2008) · JAMA · doi:10.1001/jama.299.9.1036 · Cited by 396
Oestrogen therapy for urinary incontinence in post-menopausal women
Cody, J. D., Jacobs, M. L., Richardson, K., Moehrer, B., & Hextall, A. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001405.pub3 · Cited by 391
Transdermal and oral hormone replacement therapy and the risk of stroke: a nested case-control study
Renoux, C., Dell'Aniello, S., Garbe, E., & Suissa, S. (2010) · BMJ · doi:10.1136/bmj.c2519 · Cited by 386
Salpeter, S. R., Walsh, J. M. E., Greyber, E., & Salpeter, E. E. (2006) · Journal of General Internal Medicine · doi:10.1111/j.1525-1497.2006.00389.x · Cited by 364
Postmenopausal hormones and incontinence: the heart and Estrogen/Progestin Replacement Study
Grady, D. (2001) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(00)01115-7 · Cited by 364
Effects of Conjugated Equine Estrogen on Stroke in the Women’s Health Initiative
Hendrix, S. L., Wassertheil-Smoller, S., Johnson, K. C., Howard, B. V., Kooperberg, C., Rossouw, J. E., Trevisan, M., Aragaki, A., Baird, A. E., Bray, P. F., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.594077 · Cited by 359
Local oestrogen for vaginal atrophy in postmenopausal women
Suckling, J. A., Kennedy, R., Lethaby, A., & Roberts, H. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001500.pub2 · Cited by 359
Utian, W. H., Shoupe, D., Bachmann, G., Pinkerton, J. V., & Pickar, J. H. (2001) · Fertility and Sterility · doi:10.1016/s0015-0282(01)01791-5 · Cited by 348
Increased Risk of Recurrence After Hormone Replacement Therapy in Breast Cancer Survivors
Holmberg, L., Iversen, O.-E., Rudenstam, C. M., Hammar, M., Kumpulainen, E., Jaskiewicz, J., Jassem, J., Dobaczewska, D., Fjosne, H. E., Peralta, O., et al. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn058 · Cited by 344
Eriksen, B. C. (1999) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(99)70597-1 · Cited by 336
Chlebowski, R. T., Schwartz, A. G., Wakelee, H., Anderson, G. L., Stefanick, M. L., Manson, J. E., Rodabough, R. J., Chien, J. W., Wactawski-Wende, J., Gass, M., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61526-9 · Cited by 322
Barnabei, V. M., Cochrane, B. B., Aragaki, A. K., Nygaard, I., Williams, R. S., McGovern, P. G., Young, R. L., Wells, E. C., OʼSullivan, M. J., Chen, B., et al. (2005) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000158120.47542.18 · Cited by 320
Effects of Combination Estrogen Plus Progestin Hormone Treatment on Cognition and Affect
Resnick, S. M., Maki, P. M., Rapp, S. R., Espeland, M. A., Brunner, R., Coker, L. H., Granek, I. A., Hogan, P., Ockene, J. K., & Shumaker, S. A. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2097 · Cited by 310
Hlatky, M. A., Boothroyd, D., Vittinghoff, E., Sharp, P., Whooley, M. A., & for the HERS Research Group (2002) · JAMA · doi:10.1001/jama.287.5.591 · Cited by 303
Re: Endocrine Factors and Adenocarcinoma of the Lung in Women
TAIOLI, E., & WYNDER, E. L. (1994) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/86.11.869 · Cited by 294
Breast Cancer Risk in Relation to the Interval Between Menopause and Starting Hormone Therapy
Beral, V., Reeves, G., Bull, D., Green, J., & Collaborators, F. T. M. W. S. (2011) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djq527 · Cited by 292
Health, N. I. O. (2005) · doi:10.7326/0003-4819-142-12_part_1-200506210-00117 · Cited by 290
Høibraaten, E., Qvigstad, E., Arnesen, H., Larsen, S. U., Wickström, E., & Sandset, P. (2000) · PubMed · Cited by 282
Prentice, R. L., Langer, R., Stefanick, M. L., Howard, B. V., Pettinger, M., Anderson, G., Barad, D., Curb, J. D., Kotchen, J., Kuller, L., et al. (2005) · American Journal of Epidemiology · doi:10.1093/aje/kwi223 · Cited by 264
Vickers, M. R., MacLennan, A. H., Lawton, B., Ford, D., Martin, J., Meredith, S. K., DeStavola, B. L., Rose, S., Dowell, A., Wilkes, H. C., et al. (2007) · BMJ · doi:10.1136/bmj.39266.425069.ad · Cited by 254
Unopposed Estrogen Therapy and the Risk of Invasive Breast Cancer
Chen, W. Y., Manson, J. E., Hankinson, S. E., Rosner, B., Holmes, M. D., Willett, W. C., & Colditz, G. A. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.9.1027 · Cited by 251
Lack of efficacy of estradiol for depression in postmenopausal women: a randomized, controlled trial
Morrison, M. F., Kallan, M. J., Ten Have, T., Katz, I., Tweedy, K., & Battistini, M. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2003.08.011 · Cited by 245
Heart Disease Risk Determines Menopausal Age Rather Than the Reverse
Kok, H. S., van Asselt, K. M., van der Schouw, Y. T., van der Tweel, I., Peeters, P. H. M., Wilson, P. W. F., Pearson, P. L., & Grobbee, D. E. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.12.066 · Cited by 244
Angerer, P., Störk, S., Kothny, W., Schmitt, P., & von Schacky, C. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.21.2.262 · Cited by 240
Effect of Postmenopausal Hormone Therapy on Glucose and Insulin Concentrations
Espeland, M. A., Hogan, P. E., Fineberg, S. E., Howard, G., Schrott, H., Waclawiw, M. A., Bush, T. L., & The Pepi Investigators (1998) · Diabetes Care · doi:10.2337/diacare.21.10.1589 · Cited by 239
Anderson, G. L., Chlebowski, R. T., Rossouw, J. E., Rodabough, R. J., McTiernan, A., Margolis, K. L., Aggerwal, A., Curb, J. D., Hendrix, S. L., Hubbell, F. A., et al. (2006) · Maturitas · doi:10.1016/j.maturitas.2006.05.004 · Cited by 239
Effects of Ultralow-Dose Transdermal Estradiol on Bone Mineral Density: A Randomized Clinical Trial
Ettinger, B., Ensrud, K. E., Wallace, R., Johnson, K. C., Cummings, S. R., Yankov, V., Vittinghoff, E., & Grady, D. (2004) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000137833.43248.79 · Cited by 236
Benefits and Risks of Postmenopausal Hormone Therapy When It Is Initiated Soon After Menopause
Prentice, R. L., Manson, J. E., Langer, R. D., Anderson, G. L., Pettinger, M., Jackson, R. D., Johnson, K. C., Kuller, L. H., Lane, D. S., Wactawski-Wende, J., et al. (2009) · American Journal of Epidemiology · doi:10.1093/aje/kwp115 · Cited by 234
Greendale, G. A., Wight, R. G., Huang, M. H., Avis, N., Gold, E. B., Joffe, H., Seeman, T., Vuge, M., & Karlamangla, A. S. (2010) · American Journal of Epidemiology · doi:10.1093/aje/kwq067 · Cited by 230
Hormone Replacement Therapy and the Risk of Invasive Epithelial Ovarian Cancer in Swedish Women
Riman, T. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.7.497 · Cited by 228
Hormone Therapy and Ovarian Cancer
Mørch, L. S. (2009) · JAMA · doi:10.1001/jama.2009.1052 · Cited by 226
Grady, D., Yaffe, K., Kristof, M., Lin, F., Richards, C., & Barrett-Connor, E. (2002) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01270-6 · Cited by 222
Stroke risk in women: the role of menopause and hormone therapy
Lisabeth, L., & Bushnell, C. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70269-1 · Cited by 222
Hormone Replacement Therapy and the Cardiovascular System
Ouyang, P., Michos, E. D., & Karas, R. H. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.10.076 · Cited by 217
Venous Thrombosis and Conjugated Equine Estrogen in Women Without a Uterus
Curb, J. D., Prentice, R. L., Bray, P. F., Langer, R. D., Van Horn, L., Barnabei, V. M., Bloch, M. J., Cyr, M. G., Gass, M., Lepine, L., et al. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.7.772 · Cited by 217
Bonds, D. E., Lasser, N., Qi, L., Brzyski, R., Caan, B., Heiss, G., Limacher, M. C., Liu, J. H., Mason, E., Oberman, A., et al. (2006) · Diabetologia · doi:10.1007/s00125-005-0096-0 · Cited by 213
Bayesian Meta-analysis of Hormone Therapy and Mortality in Younger Postmenopausal Women
Salpeter, S. R., Cheng, J., Thabane, L., Buckley, N. S., & Salpeter, E. E. (2009) · The American Journal of Medicine · doi:10.1016/j.amjmed.2009.05.021 · Cited by 201
Symptom Experience After Discontinuing Use of Estrogen Plus Progestin
Ockene, J. K. (2005) · JAMA · doi:10.1001/jama.294.2.183 · Cited by 200
Oral Medroxyprogesterone in the Treatment of Postmenopausal Symptoms
Schiff, I. (1980) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1980.03310130021021 · Cited by 199
Grodstein, F., Manson, J. E., Stampfer, M. J., & Rexrode, K. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.8.861 · Cited by 192
Jacoby, V. L., Grady, D., Wactawski-Wende, J., Manson, J. E., Allison, M. A., Kuppermann, M., Sarto, G. E., Robbins, J., Phillips, L., Martin, L. W., et al. (2011) · Archives of Internal Medicine · doi:10.1001/archinternmed.2011.121 · Cited by 188
Breast Cancer Risk in Relation to the Interval Between Menopause and Starting Hormone Therapy
Day, S., & Bevers, T. B. (2011) · Breast Diseases: A Year Book Quarterly · doi:10.1016/j.breastdis.2011.10.032 · Cited by 187
Hormone Replacement Therapy and Lung Cancer Risk
Schabath, M. B., Wu, X., Vassilopoulou-Sellin, R., Vaporciyan, A. A., & Spitz, M. R. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0911-3 · Cited by 184
Qvigstad, E., Arnesen, H., Larsen, S., Wickstrøm, E., Sandset, P., & Høibraaten, E. (2000) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1614156 · Cited by 184
Menopausal symptoms in older women and the effects of treatment with hormone therapy
Barnabei, V (2002) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(02)02369-4 · Cited by 165
Lung Cancer and Hormone Replacement Therapy: Association in the Vitamins and Lifestyle Study
Slatore, C. G., Chien, J. W., Au, D. H., Satia, J. A., & White, E. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.9739 · Cited by 162
Shou-qin, L. (2008) · Zhongguo shiyong fuke yu chanke zazhi · Cited by 156
Surgical versus natural menopause: cognitive issues
Henderson, V. W., & Sherwin, B. B. (2007) · Menopause · doi:10.1097/gme.0b013e31803df49c · Cited by 154
Schwartz, A. G., Wenzlaff, A. S., Prysak, G. M., Murphy, V., Coté, M. L., Brooks, S. C., Skafar, D. F., & Lonardo, F. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.3975 · Cited by 153
Endocrine Aspects of Female Sexual Dysfunction
Davis, S. R., Guay, A. T., Shifren, J. L., & Mazer, N. A. (2004) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2004.10112.x · Cited by 151
Fournier, A., Mesrine, S., Boutron‐Ruault, M., & Clavel‐Chapelon, F. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.21.6432 · Cited by 151
Herrington, D. M., Vittinghoff, E., Howard, T. D., Major, D. A., Owen, J. D., Reboussin, D. M., Bowden, D. W., Bittner, V., Simon, J. A., Grady, D. G., et al. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000018301.91721.94 · Cited by 151
Liu, Y., Inoue, M., Sobue, T., Tsugane, S., & for the JPHC Study Group (2005) · International Journal of Cancer · doi:10.1002/ijc.21229 · Cited by 146
Oestrogen therapy for urinary incontinence in post-menopausal women
Cody, J. D., Richardson, K., Moehrer, B., Hextall, A., & Glazener, C. M. A. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001405.pub2 · Cited by 141
Effects of hormone replacement therapy on cognitive performance in elderly women
Binder, E. F., Schechtman, K. B., Birge, S. J., Williams, D. B., & Kohrt, W. M. (2001) · Maturitas · doi:10.1016/s0378-5122(00)00214-0 · Cited by 137
Endocrine Aspects of Women’s Sexual Function
Wierman, M. E., Nappi, R. E., Avis, N. E., Davis, S. R., Labrie, F., Rosner, W., & Shifren, J. L. (2010) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2009.01629.x · Cited by 137
Prentice, R. L., Chlebowski, R. T., Stefanick, M. L., Manson, J. E., Langer, R. D., Pettinger, M. B., Hendrix, S. L., Hubbell, F. A., Kooperberg, C. L., Kuller, L. H., et al. (2008) · American Journal of Epidemiology · doi:10.1093/aje/kwn090 · Cited by 135
Estrogen and coronary heart disease in women
Barrett-Connor, E. L., & Bush, T. (1992) · International Journal of Gynecology & Obstetrics · doi:10.1016/0020-7292(92)90420-n · Cited by 133
Hip fracture in postmenopausal women after cessation of hormone therapy
Karim, R., Dell, R. M., Greene, D. F., Mack, W. J., Gallagher, J. C., & Hodis, H. N. (2011) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e31821b01c7 · Cited by 125
Chlebowski, R. T., Anderson, G. L., Manson, J. E., Schwartz, A. G., Wakelee, H. A., Gass, M. L. S., Rodabough, R. J., Johnson, K., Wactawski‐Wende, J., Kotchen, J. M., et al. (2010) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djq285 · Cited by 125
The role of local vaginal estrogen for treatment of vaginal atrophy in postmenopausal women
(2007) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e31805170eb · Cited by 124
Toh, S., Hernández–Díaz, S., Logan, R. W., Rossouw, J. E., & Hernán, M. Á. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-152-4-201002160-00005 · Cited by 123
Brunner, R. L. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.17.1976 · Cited by 122
Joffe, H., Petrillo, L. F., Koukopoulos, A. E., Viguera, A. C., Hirschberg, A., Nonacs, R. M., Somley, B., Cahill, E. P., White, D. P., Hall, J. E., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2503 · Cited by 122
Menopausal hormone therapy and risk of ovarian cancer: systematic review and meta-analysis
Greiser, C. M., Greiser, E. M., & Dören, M. (2007) · Human Reproduction Update · doi:10.1093/humupd/dmm012 · Cited by 122
Lacey, J. V., Brinton, L. A., Leitzmann, M. F., Mouw, T., Hollenbeck, A. R., Schatzkin, A. G., & Hartge, P. A. (2006) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djj375 · Cited by 120
Hormone therapy and risk of myocardial infarction: a national register study
Løkkegaard, E., Andreasen, A. H., Jacobsen, R. K., Nielsen, L. H., Agger, C., & Lidegaard, Ø. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn408 · Cited by 120
Loprinzi, C. L. (2010) · International Journal of Women s Health · doi:10.2147/ijwh.s7721 · Cited by 117
Hormone Therapy and the Impact of Estrogen Intake on the Risk of Ovarian Cancer
Glud, E., Kjær, S. K., Thomsen, B. L., Høgdall, C. K., Christensen, L. H., Høgdall, E. V. S., Bock, J. E., & Blaakær, J. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.20.2253 · Cited by 115
Brunner, R. L., Aragaki, A. K., Barnabei, V. M., et al. (2010) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e3181d76953 · Cited by 115
Hormone replacement therapy and risk of epithelial ovarian cancer
Purdie, D. M., Bain, C., Siskind, V., Russell, P. J., Hacker, N. F., Ward, B. G., Quinn, M. A., & Green, A. C. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690731 · Cited by 112
Menopausal Hormone Therapy and Risk of Epithelial Ovarian Cancer
Rossing, M. A., Cushing‐Haugen, K. L., Wicklund, K. G., Doherty, J. A., & Weiss, N. S. (2007) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-0550 · Cited by 110
Noncontraceptive Estrogen Use and the Occurrence of Ovarian Cancer 1 2
Vecchia, C. L., Liberati, A., & Franceschi, S. (1982) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/69.6.1207 · Cited by 109
Resnick, S. M., Espeland, M. A., An, Y., Maki, P. M., Coker, L. H., Jackson, R. D., Stefanick, M. L., Wallace, R. B., Rapp, S. R., & for the Women’s Health Initiative Study of Cognitive Aging Investigators (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1340 · Cited by 108
Laliberté, F., Dea, K., Duh, M. S., Kahler, K. H., Rolli, M., & Lefèbvre, P. (2011) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e3182175e5c · Cited by 108
Col, N. F., Kim, J. A., & Chlebowski, R. T. (2005) · Breast Cancer Research · doi:10.1186/bcr1035 · Cited by 105
Postmenopausal hormone therapy and risk of cognitive decline in community-dwelling aging women
Kang, J. H., Weuve, J., & Grodstein, F. (2004) · Neurology · doi:10.1212/01.wnl.0000132522.13574.67 · Cited by 90
Gass, M. L. S., Cochrane, B. B., Larson, J. C., Manson, J. E., Barnabei, V. M., Brzyski, R. G., Lane, D. S., Valleur, J. L., Ockene, J. K., Mouton, C. P., et al. (2011) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e3182227ebd · Cited by 88
Nelken, R. S., Özel, B. Z., Leegant, A., Felix, J. C., & Mishell, D. R. (2011) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e3182104977 · Cited by 86
Vaidya, D. M., Becker, D. M., Bittner, V., Mathias, R. A., & Ouyang, P. (2011) · BMJ · doi:10.1136/bmj.d5170 · Cited by 84
Rasgon, N., Dunkin, J. J., Fairbanks, L. A., Altshuler, L. L., Troung, C., Elman, S., Wroolie, T., Brunhuber, M. V., & Rapkin, A. J. (2006) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2006.03.009 · Cited by 81
Lowest Effective Transdermal 17β-Estradiol Dose for Relief of Hot Flushes in Postmenopausal Women
Bachmann, G. A., Schaefers, M., Uddin, A., & Utian, W. H. (2007) · Obstetrics and Gynecology · doi:10.1097/01.aog.0000284450.51264.31 · Cited by 80
Elliott, A. M., & Hannaford, P. C. (2005) · Contraception · doi:10.1016/j.contraception.2005.10.003 · Cited by 79
Are Smoking-Associated Cancers Prevented or Postponed in Women Using Hormone Replacement Therapy?
Olsson, H. L., Bladström, A., & Ingvar, C. (2003) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(03)00564-7 · Cited by 75
The incidence of urinary incontinence across Asian, black, and white women in the United States
Townsend, M. K., Curhan, G. C., Resnick, N. M., & Grodstein, F. (2009) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2009.11.021 · Cited by 71
Jordan, V. C., & Ford, L. G. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-11-0185 · Cited by 70
Somboonporn, W., Panna, S., Temtanakitpaisan, T., Kaewrudee, S., & Soontrapa, S. (2011) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e31821606c5 · Cited by 69
Hormone Replacement Therapy Is Associated with Less Coronary Atherosclerosis in Postmenopausal Women
Akhrass, F., Evans, A. T., Wang, Y., Rich, S., Kannan, C. R., Fogelfeld, L. A., & Mazzone, T. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031008 · Cited by 66
Endometrial Cancer in Postmenopausal Women Using Estradiol–Progestin Therapy
Jaakkola, S., Lyytinen, H. K., Pukkala, ., & Ylikorkala, O. (2009) · Obstetrics and Gynecology · doi:10.1097/aog.0b013e3181bea950 · Cited by 65
Breast Cancer Survival and Hormone Replacement Therapy
DiSaia, P. J., Brewster, W. R., Ziogas, A., & Anton‐Culver, H. (2000) · American Journal of Clinical Oncology · doi:10.1097/00000421-200012000-00001 · Cited by 64
Activated protein C resistance among postmenopausal women using transdermal estrogens
Canonico, M., Alhenc‐Gelas, M., Plu‐Bureau, G., Olié, V., & Scarabin, P. (2010) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e3181e102eb · Cited by 59
Beckmann, M. W., Jap, D., Djahansouzi, S., Nestle-Krämling, C., Kuschel, B., Dall, P., Brumm, C., & Bender, H. (2001) · Oncology · doi:10.1159/000055319 · Cited by 59
Uterine and Vaginal Effects of Unopposed Ultralow-Dose Transdermal Estradiol
Johnson, S. R., Ettinger, B. B., Macer, J. L., Ensrud, K. E., Quan, J., & Grady, D. G. (2005) · Obstetrics and Gynecology · doi:10.1097/01.aog.0000157116.23249.52 · Cited by 59
Postmenopausal Hormone Use and the Risk of Nephrolithiasis
Maalouf, N. M., Sato, A., Welch, B. J., et al. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.342 · Cited by 58
A case-control study of hormone replacement therapy after primary surgical breast cancer treatment
Uršič-Vrščaj, M., & Bebar, S. (1999) · European Journal of Surgical Oncology · doi:10.1053/ejso.1998.0617 · Cited by 55
Progestogens and venous thromboembolism among postmenopausal women using hormone therapy
Canonico, M., Plu‐Bureau, G., & Scarabin, P. (2011) · Maturitas · doi:10.1016/j.maturitas.2011.10.002 · Cited by 54
Gonadal Hormones and Cognitive Aging: A Midlife Perspective
Henderson, V. W. (2010) · Women s Health · doi:10.2217/whe.10.87 · Cited by 54
Hormone replacement therapy after a diagnosis of breast cancer: cancer recurrence and mortality
Durna, E. M., Leader, L. R., Sjöblom, P., et al. (2002) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2002.tb04835.x · Cited by 53
Barrett-Connor, E. L., & Laughlin, G. A. (2005) · Menopause The Journal of The North American Menopause Society · doi:10.1097/00042192-200512010-00009 · Cited by 46
The Effect of Ultralow-Dose Transdermal Estradiol on Urinary Incontinence in Postmenopausal Women
Waetjen, L. E., Brown, J. S., Vittinghoff, E., Ensrud, K. E., Pinkerton, J. V., Wallace, R. B., Macer, J. L., & Grady, D. G. (2005) · Obstetrics and Gynecology · doi:10.1097/01.aog.0000182576.48290.6d · Cited by 44
Estrogen replacement therapy in breast cancer survivors: a matched-controlled series
Decker, D. A., Pettinga, J., VanderVelde, N., Huang, R., Kestin, L. L., & Burdakin, J. H. (2003) · Menopause The Journal of The North American Menopause Society · doi:10.1097/01.gme.0000061806.76067.e9 · Cited by 44
Hormone therapy and cerebrovascular events: a population-based nested case-control study
Arana, A., Varas‐Lorenzo, C., González‐Pérez, A., Gutiérrez, L., Bjerrum, L., & Rodríguez, L. A. G. (2006) · Menopause The Journal of The North American Menopause Society · doi:10.1097/01.gme.0000233494.28335.71 · Cited by 43
Ramnath, N., Menezes, R. J., Loewen, G., Dua, P., Eid, F., Alkhaddo, J. B., Paganelli, G. M., Natarajan, N., & Reid, M. E. (2007) · Oncology · doi:10.1159/000134238 · Cited by 43
&NA; (2006) · Journal of Burn Care & Research · doi:10.1097/01.gme.0000186663.36211.c0 · Cited by 42
Trémollières, F., Cigagna, F., Alquier, C., Cauneille, C., Pouillès, J. M., & Ribot, C. A. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(00)00372-5 · Cited by 42
Barrett-Connor, E. L., Wenger, N. K., Grady, D., Mosca, L. J., Collins, P. D., Kornitzer, M., Cox, D. A., Moscarelli, E., & Anderson, P. W. (1998) · Maturitas · doi:10.1016/s0378-5122(98)00099-1 · Cited by 42
Marttunen, M. B., Hietanen, P. S., Pyrhönen, S. O., Tiitinen, A. E., & Ylikorkala, O. (2001) · Maturitas · doi:10.1016/s0378-5122(01)00211-0 · Cited by 36
Michael, Y. L., Gold, R. B., Manson, J. E., Keast, E. M., Cochrane, B. B., Woods, N. F., Brzyski, R. G., McNeeley, S. G., & Wallace, R. B. (2010) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e3181ba56c7 · Cited by 36
Misconception and Concerns about Bioidentical Hormones Used for Custom-Compounded Hormone Therapy
Bhavnani, B. R., & Stanczyk, F. Z. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2492 · Cited by 36
Hormone Therapy and Risk of Lung Cancer: A Meta-Analysis
Oh, S., Myung, S., Park, J. Y., Lym, Y. L., & Ju, W. (2010) · Journal of Women s Health · doi:10.1089/jwh.2009.1434 · Cited by 32
Surgical menopause and nonvertebral fracture risk among older US women
Vesco, K. K., Marshall, L. M., Nelson, H. D., Humphrey, L. L., Rizzo, J. H., Pedula, K. L., Cauley, J. A., Ensrud, K. E., Hochberg, M. C., Antoniucci, D. M., et al. (2011) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e318239caeb · Cited by 25
Schisterman, E. F., Gallagher, A. M., Merz, C. N. B., Whitcomb, B. W., Faraggi, D., Moysich, K. B., & Lewin, H. C. (2002) · Journal of Women s Health & Gender-Based Medicine · doi:10.1089/152460902760360577 · Cited by 17
Endometriosis-Associated Intestinal Tumours: A Consequence of Long-Term Unopposed Oestrogen?
Efthymiou, C. A. (2009) · Annals of The Royal College of Surgeons of England · doi:10.1308/003588409x391848 · Cited by 11
Cited by
The role of estrogens in control of energy balance and glucose homeostasis
Mauvais-Jarvis, F., Clegg, D. J., & Hevener, A. L. (2013) · Endocrine Reviews · doi:10.1210/er.2012-1055 · Cited by 1,329
Jellinger, P. S., Handelsman, Y., Rosenblit, P. D., Bloomgarden, Z. T., Fonseca, V. A., Garber, A. J., Grunberger, G., Guerin, C. K., Bell, D. S. H., Mechanick, J. I., et al. (2017) · Endocrine Practice · doi:10.4158/ep171764.appgl · Cited by 1,094
2016 IMS Recommendations on women’s midlife health and menopause hormone therapy
Baber, R. J., Panay, N., & Fenton, A. (2016) · Climacteric · doi:10.3109/13697137.2015.1129166 · Cited by 964
Treatment of symptoms of the menopause: an Endocrine Society Clinical Practice Guideline
Stuenkel, C. A., Davis, S. R., Gompel, A., Lumsden, M. A., Murad, M. H., Pinkerton, J. V., & Santen, R. J. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2236 · Cited by 884
Sammaritano, L. R., Bermas, B. L., Chakravarty, E. E., Chambers, C., Clowse, M. E. B., Lockshin, M. D., Marder, W., Guyatt, G., Branch, D. W., Buyon, J., et al. (2020) · Arthritis & Rheumatology · doi:10.1002/art.41191 · Cited by 790
Metadata
- Venue
- Menopause
- Published
- 2012-03
- Volume
- 19
- Issue
- 3
- Pages
- 257-271
- ISSN
- 1072-3714 (ISSN-L)
- OpenAlex
- W2112457093
- Cited by
- 785
- References
- 167
- FWCI
- 79.16
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.